Analysis of application and funded projects of National Natural Science Foundation of China in Clinical Pharmacology from 2015 to 2024
10.13699/j.cnki.1001-6821.2025.02.001
- VernacularTitle:2015-2024年国家自然科学基金临床药理学领域申请与资助项目分析
- Author:
Nan ZHENG
1
;
Yue LIU
;
Li-wei HAN
Author Information
1. 国家自然科学基金委员会医学科学部,北京 100085;首都医科大学附属北京安定医院国家精神心理疾病临床医学研究中心,精神疾病诊断与治疗北京市重点实验室,北京 100088
- Publication Type:Journal Article
- Keywords:
clinical pharmacology;
National Natural Science Foundation of China;
the application and funded project
- From:
The Chinese Journal of Clinical Pharmacology
2025;41(2):151-158
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the application and funded projects in the field of clinical pharmacology supported by the National Natural Science Foundation of China(NSFC)from 2015 to 2024,aiming to provide a reference for the application.Methods Information on the application and funded projects under the"Clinical Pharmacology(H3511)"code from 2015 to 2024 was collected from the NSFC management information system,including funding year,project name,project category,funding amount,keywords,research directions,etc.A database was established based on this information for statistical analysis.Results From 2015 to 2024,2 031 applications were received for general,young scientist,and regional scientist foundation in the clinical pharmacology research field,with 320 projects funded,accumulating a direct funding of 118.48 million yuan.The number and amount of funded projects showed a fluctuating upward trend.The diseases studied in the applications were mainly concentrated in malignant tumors,cardiovascular and cerebrovascular diseases,neuropsychiatric diseases,and metabolic diseases.The research directions of the applications and funded projects were mainly focused on personalized medication,drug adverse reactions and toxicity,and clinical biomarkers,accounting for 67.6％and 70.3％of the total number of application and funded projects,respectively.Conclusion With the emergence of new methods and technologies,clinical pharmacology has developed rapidly,and basic research in this field has increasingly attracted attention.The NSFC has always emphasized support for this field.However,there are still some issues of the applications,such as the need to strengthen clinical characteristics,uneven distribution of disease types and research directions,and unbalanced development within the discipline,which require increased attention from clinical pharmacology researchers.
